Olympiad Research’s Acceleron Pharma XLRN Stock Holding History

Olympiad Research’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-5,717	Closed	-$984K	–	323
2021 Q3	$984K	Buy	+5,717	New	+$748K	0.3%	105

Olympiad Research's XLRN Position: Q4 2021 in Review

Olympiad Research sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 5,717 shares — an estimated $984K sold.

Olympiad Research first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $984K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Olympiad Research reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Olympiad Research sold 5,717 Acceleron Pharma shares in Q4 2021, an estimated $984K.
Olympiad Research first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
Olympiad Research's Acceleron Pharma position peaked at $984K in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Olympiad Research's 13F filing for Q4 2021, filed 9 Feb 2022.